Friday 7 April marks the World Health Organization's (WHO) World Health Day, and this year's focus is depression. More than 300 million people live with the condition, and WHO encourages more people to seek help for their depression – the leading cause of ill health and disability worldwide. Read The Pharmaceutical Journal's special report on depression and improve your support for patients with this mental health condition.
Pharmacists and healthcare professionals should be able to recognise the symptoms of depression in people who use their services and direct them towards accessing treatment. This article examines how a diagnosis of depression is made, the pharmacological and non-pharmacological treatments available, specific considerations for different patient groups, self-management approaches, and the role of the pharmacy team in managing and supporting patients who have symptoms of depression.
Personalised treatment for depression on the horizon: predicting response to antidepressantsSubscription
Only one-third of patients with depression benefit from the first antidepressant they try, but researchers are striving to find biological features that predict how a person will respond to particular drugs so they can tailor treatment from the beginning.
Despite criticism about antidepressants in the media and rising calls for non-drug therapies for depression, evidence indicates that drugs are still the most effective treatment.
Patients with no CYP2C19 enzyme expression in the womb had a lower prevalence of depressive disorder compared with those who expressed the enzyme, researchers found.
Emergency hormonal contraception should be available to buy from non-pharmacy retail outlets in the UK, urges the British Pregnancy Advisory Service, a reproductive health services charity.
Anti-cytokine drugs typically prescribed to treat inflammatory conditions, such as rheumatoid arthritis and psoriasis, can also improve symptoms of depression, according to new research.
Filling the gap in mental health researchSubscription
Ways to tackle the lack of funding in mental health research.
As a multi-site pharmacy manager for LloydsPharmacy and lead pharmacist based in the Carleton Clinic, a mental health hospital in Carlisle, John Mowat talks about his career and role in providing the medication supply service for Cumbria Partnership Foundation Trust.
In light of singer Adele’s recent admission in an interview that she has suffered from postnatal depression (PND), I would like to alert readers to how they can spot the signs and help those who might be affected in their day-to-day work in the pharmacy.
Around one in four people in the UK experience a mental health condition each year. Currently, up to two-thirds of those affected are going without treatment. We lack the tools to diagnose many mental illnesses quickly or effectively enough, and treatments do not work well enough for too many people.